These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31516691)

  • 1. Patients' attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators.
    Eveleigh R; Speckens A; van Weel C; Oude Voshaar R; Lucassen P
    Ther Adv Psychopharmacol; 2019; 9():2045125319872344. PubMed ID: 31516691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
    Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
    Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REDUCE (Reviewing long-term antidepressant use by careful monitoring in everyday practice) internet and telephone support to people coming off long-term antidepressants: protocol for a randomised controlled trial.
    Kendrick T; Geraghty AWA; Bowers H; Stuart B; Leydon G; May C; Yao G; O'Brien W; Glowacka M; Holley S; Williams S; Zhu S; Dewar-Haggart R; Palmer B; Bell M; Collinson S; Fry I; Lewis G; Griffiths G; Gilbody S; Moncrieff J; Moore M; Macleod U; Little P; Dowrick C
    Trials; 2020 May; 21(1):419. PubMed ID: 32448374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuing antidepressant medication after mindfulness-based cognitive therapy: a mixed-methods study exploring predictors and outcomes of different discontinuation trajectories, and its facilitators and barriers.
    Huijbers MJ; Wentink C; Simons E; Spijker J; Speckens A
    BMJ Open; 2020 Nov; 10(11):e039053. PubMed ID: 33177138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of antidepressant medication in primary care supported by monitoring plus mindfulness-based cognitive therapy versus monitoring alone: design and protocol of a cluster randomized controlled trial.
    Wentink C; Huijbers MJ; Lucassen P; Kramers C; Akkermans R; Adang E; Spijker J; Speckens AEM
    BMC Fam Pract; 2019 Jul; 20(1):105. PubMed ID: 31349796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should I, can I, dare I? Patients' view on stopping long-term antidepressant use, a qualitative study.
    Van Leeuwen E; Anthierens S; van Driel ML; De Sutter A; De Beir R; Christiaens T
    Acta Clin Belg; 2022 Dec; 77(6):962-969. PubMed ID: 35007191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Never change a winning team': GPs' perspectives on discontinuation of long-term antidepressants.
    Ellen VL; Anthierens S; van Driel ML; Sutter A; Branden EVD; Christiaens T
    Scand J Prim Health Care; 2021 Dec; 39(4):533-542. PubMed ID: 34895003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care.
    Eveleigh R; Muskens E; Lucassen P; Verhaak P; Spijker J; van Weel C; Oude Voshaar R; Speckens A
    BJGP Open; 2018 Jan; 1(4):bjgpopen17X101265. PubMed ID: 30564695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term antidepressant use: a qualitative study on perspectives of patients and GPs in primary care.
    Bosman RC; Huijbregts KM; Verhaak PF; Ruhé HG; van Marwijk HW; van Balkom AJ; Batelaan NM
    Br J Gen Pract; 2016 Oct; 66(651):e708-19. PubMed ID: 27528709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial.
    Bockting CLH; Klein NS; Elgersma HJ; van Rijsbergen GD; Slofstra C; Ormel J; Buskens E; Dekker J; de Jong PJ; Nolen WA; Schene AH; Hollon SD; Burger H
    Lancet Psychiatry; 2018 May; 5(5):401-410. PubMed ID: 29625762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of a treatment advice to discontinue inappropriate long-term antidepressant use in primary care.
    Eveleigh R; Grutters J; Muskens E; Oude Voshaar R; van Weel C; Speckens A; Lucassen P
    Fam Pract; 2014 Oct; 31(5):578-84. PubMed ID: 25121977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and facilitators to discontinuing antidepressant use: A systematic review and thematic synthesis.
    Maund E; Dewar-Haggart R; Williams S; Bowers H; Geraghty AWA; Leydon G; May C; Dawson S; Kendrick T
    J Affect Disord; 2019 Feb; 245():38-62. PubMed ID: 30366236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials.
    Batelaan NM; Bosman RC; Muntingh A; Scholten WD; Huijbregts KM; van Balkom AJLM
    BMJ; 2017 Sep; 358():j3927. PubMed ID: 28903922
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term prescribing of antidepressants in the older population: a qualitative study.
    Dickinson R; Knapp P; House AO; Dimri V; Zermansky A; Petty D; Holmes J; Raynor DK
    Br J Gen Pract; 2010 Apr; 60(573):e144-55. PubMed ID: 20353660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S
    Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'I just thought that it was such an impossible thing': A qualitative study of barriers and facilitators to discontinuing long-term use of benzodiazepine receptor agonists using the Theoretical Domains Framework.
    Lynch T; Ryan C; Cadogan CA
    Health Expect; 2022 Feb; 25(1):355-365. PubMed ID: 34862703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing ANtiDepressants Appropriately (PANDA): a cluster randomized controlled trial in primary care.
    Muskens E; Eveleigh R; Lucassen P; van Weel C; Spijker J; Verhaak P; Speckens A; Voshaar RO
    BMC Fam Pract; 2013 Jan; 14():6. PubMed ID: 23297810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Digital Intervention for Primary Care Practitioners to Support Antidepressant Discontinuation (Advisor for Health Professionals): Development Study.
    Bowers H; Kendrick T; van Ginneken N; Glowacka M; Williams S; Leydon GM; May C; Dowrick C; Moncrieff J; Johnson CF; Moore M; Laine R; Geraghty AWA
    J Med Internet Res; 2021 Jul; 23(7):e25537. PubMed ID: 34269688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescriber intent, off-label usage, and early discontinuation of antidepressants: a retrospective physician survey and data analysis.
    Pomerantz JM; Finkelstein SN; Berndt ER; Poret AW; Walker LE; Alber RC; Kadiyam V; Das M; Boss DT; Ebert TH
    J Clin Psychiatry; 2004 Mar; 65(3):395-404. PubMed ID: 15096080
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.